287 related articles for article (PubMed ID: 30806315)
21. Contribution of polymorphisms in IKZF1 gene to childhood acute leukemia: a meta-analysis of 33 case-control studies.
Dai YE; Tang L; Healy J; Sinnett D
PLoS One; 2014; 9(11):e113748. PubMed ID: 25423013
[TBL] [Abstract][Full Text] [Related]
22. Minimal residual disease, long-term outcome, and IKZF1 deletions in children and adolescents with Down syndrome and acute lymphocytic leukaemia: a matched cohort study.
Michels N; Boer JM; Enshaei A; Sutton R; Heyman M; Ebert S; Fiocco M; de Groot-Kruseman HA; van der Velden VHJ; Barbany G; Escherich G; Vora A; Trahair T; Dalla-Pozza L; Pieters R; Zur Stadt U; Schmiegelow K; Moorman AV; Zwaan CM; den Boer ML
Lancet Haematol; 2021 Oct; 8(10):e700-e710. PubMed ID: 34560013
[TBL] [Abstract][Full Text] [Related]
23. Association of genetic variation in IKZF1, ARID5B, and CEBPE and surrogates for early-life infections with the risk of acute lymphoblastic leukemia in Hispanic children.
Hsu LI; Chokkalingam AP; Briggs FB; Walsh K; Crouse V; Fu C; Metayer C; Wiemels JL; Barcellos LF; Buffler PA
Cancer Causes Control; 2015 Apr; 26(4):609-19. PubMed ID: 25761407
[TBL] [Abstract][Full Text] [Related]
24. High frequency of the risk allele of rs4132601 and rs11978267 from the IKZF1 gene in indigenous Mexican population.
Gutiérrez-Franco J; Ayón-Pérez MF; Durán-Avelar MJ; Vibanco-Pérez N; Sánchez-Jasso DE; Bañuelos-Aguayo DG; Sánchez-Meza J; Pimentel-Gutiérrez HJ; Zambrano-Zaragoza JF; Agraz-Cibrián JM; Vázquez-Reyes A
Mol Genet Genomic Med; 2021 Feb; 9(2):e1589. PubMed ID: 33452870
[TBL] [Abstract][Full Text] [Related]
25. Genetic polymorphisms in ARID5B, CEBPE, IKZF1 and CDKN2A in relation with risk of acute lymphoblastic leukaemia in adults: a Group for Research on Adult Acute Lymphoblastic Leukaemia (GRAALL) study.
Peyrouze P; Guihard S; Grardel N; Berthon C; Pottier N; Pigneux A; Cahn JY; Béné MC; Lhéritier V; Delabesse E; Macintyre E; Thomas X; Dombret H; Ifrah N; Cheok M
Br J Haematol; 2012 Dec; 159(5):599-602. PubMed ID: 23016962
[No Abstract] [Full Text] [Related]
26. Association of ARID5B and IKZF1 Variants with Leukemia from Northern India.
Bhat A; Shah R; Bhat GR; Verma S; Sharma V; Sharma I; Pandita M; Bakshi D; Sharma B; Suri J; Kumar R
Genet Test Mol Biomarkers; 2019 Mar; 23(3):176-179. PubMed ID: 30810385
[TBL] [Abstract][Full Text] [Related]
27. ARID5B and IKZF1 variants, selected demographic factors, and childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Linabery AM; Blommer CN; Spector LG; Davies SM; Robison LL; Ross JA
Leuk Res; 2013 Aug; 37(8):936-42. PubMed ID: 23692655
[TBL] [Abstract][Full Text] [Related]
28. Association of three polymorphisms in ARID5B, IKZF1 and CEBPE with the risk of childhood acute lymphoblastic leukemia in a Chinese population.
Wang Y; Chen J; Li J; Deng J; Rui Y; Lu Q; Wang M; Tong N; Zhang Z; Fang Y
Gene; 2013 Jul; 524(2):203-7. PubMed ID: 23608171
[TBL] [Abstract][Full Text] [Related]
29. Confirmation of childhood acute lymphoblastic leukemia variants, ARID5B and IKZF1, and interaction with parental environmental exposures.
Evans TJ; Milne E; Anderson D; de Klerk NH; Jamieson SE; Talseth-Palmer BA; Bowden NA; Holliday EG; Rudant J; Orsi L; Richardson E; Lavis L; Catchpoole D; Attia JR; Armstrong BK; Clavel J; Scott RJ
PLoS One; 2014; 9(10):e110255. PubMed ID: 25310577
[TBL] [Abstract][Full Text] [Related]
30. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
[TBL] [Abstract][Full Text] [Related]
31. Methylenetetrahydrofolate reductase C677T and A1298C polymorphism and susceptibility to acute lymphoblastic leukemia in a cohort of Egyptian children.
Mosaad YM; Abousamra NK; Elashery R; Fawzy IM; Eldein OA; Sherief DM; El Azab HM
Leuk Lymphoma; 2015; 56(9):2699-705. PubMed ID: 25629981
[TBL] [Abstract][Full Text] [Related]
32. The clinical impact of IKZF1 deletions in paediatric B-cell precursor acute lymphoblastic leukaemia is independent of minimal residual disease stratification in Nordic Society for Paediatric Haematology and Oncology treatment protocols used between 1992 and 2013.
Olsson L; Ivanov Öfverholm I; Norén-Nyström U; Zachariadis V; Nordlund J; Sjögren H; Golovleva I; Nordgren A; Paulsson K; Heyman M; Barbany G; Johansson B
Br J Haematol; 2015 Sep; 170(6):847-58. PubMed ID: 26018335
[TBL] [Abstract][Full Text] [Related]
33. [Relationship between IKZF3 Gene Single Nucleotide Polymorphisms and Childhood Acute Lymphoblastic Leukemia].
Hong Y; Wang Q; Song YL; Liu GM; Yang X; Yan MX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):690-695. PubMed ID: 34105458
[TBL] [Abstract][Full Text] [Related]
34. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia.
Papaemmanuil E; Hosking FJ; Vijayakrishnan J; Price A; Olver B; Sheridan E; Kinsey SE; Lightfoot T; Roman E; Irving JA; Allan JM; Tomlinson IP; Taylor M; Greaves M; Houlston RS
Nat Genet; 2009 Sep; 41(9):1006-10. PubMed ID: 19684604
[TBL] [Abstract][Full Text] [Related]
35. Childhood acute lymphoblastic leukemia-associated risk-loci IKZF1, ARID5B and CEBPE and risk of pediatric non-Hodgkin lymphoma: a report from the Berlin-Frankfurt-Münster Study Group.
Bartram T; Burkhardt B; Wössmann W; Seidemann K; Zimmermann M; Cario G; Lisfeld J; Ellinghaus E; Franke A; Houlston RS; Schrappe M; Reiter A; Stanulla M
Leuk Lymphoma; 2015 Mar; 56(3):814-6. PubMed ID: 25005032
[No Abstract] [Full Text] [Related]
36. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros.
Mullighan CG; Miller CB; Radtke I; Phillips LA; Dalton J; Ma J; White D; Hughes TP; Le Beau MM; Pui CH; Relling MV; Shurtleff SA; Downing JR
Nature; 2008 May; 453(7191):110-4. PubMed ID: 18408710
[TBL] [Abstract][Full Text] [Related]
37. Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.
Volejnikova J; Mejstrikova E; Dörge P; Meissner B; Zimmermannova O; Svojgr K; Stanulla M; Cario G; Schrappe M; Stary J; Hrusak O; Trka J; Fronkova E
Pediatr Blood Cancer; 2013 Mar; 60(3):420-7. PubMed ID: 22997141
[TBL] [Abstract][Full Text] [Related]
38. Methylene tetrahydrofolate reductase gene polymorphism in Egyptian children with acute lymphoblastic leukemia.
Tantawy AA; El-Bostany EA; Adly AA; Abou El Asrar M; El-Ghouroury EA; Abdulghaffar EE
Blood Coagul Fibrinolysis; 2010 Jan; 21(1):28-34. PubMed ID: 19923983
[TBL] [Abstract][Full Text] [Related]
39. Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations.
Xu H; Yang W; Perez-Andreu V; Devidas M; Fan Y; Cheng C; Pei D; Scheet P; Burchard EG; Eng C; Huntsman S; Torgerson DG; Dean M; Winick NJ; Martin PL; Camitta BM; Bowman WP; Willman CL; Carroll WL; Mullighan CG; Bhojwani D; Hunger SP; Pui CH; Evans WE; Relling MV; Loh ML; Yang JJ
J Natl Cancer Inst; 2013 May; 105(10):733-42. PubMed ID: 23512250
[TBL] [Abstract][Full Text] [Related]
40. Microdeletion of 7p12.1p13, including IKZF1, causes intellectual impairment, overgrowth, and susceptibility to leukaemia.
Järviaho T; Zachariadis V; Tesi B; Chiang S; Bryceson YT; Möttönen M; Niinimäki R; Bang B; Rahikkala E; Taylan F; Uusimaa J; Harila-Saari A; Nordgren A
Br J Haematol; 2019 Apr; 185(2):354-357. PubMed ID: 30004112
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
